Factor structure and longitudinal measurement invariance of PHQ-9 for specialist mental health care patients with persistent major depressive disorder: Exploratory Structural Equation Modelling by Guo, Boliang et al.
1Factor structure and longitudinal measurement invariance of PHQ-9 for specialist mental
health care patients with persistent major depressive disorder: Exploratory Structural
Equation Modelling
Boliang Guo
Catherine Kaylor-Hughes
Anne Garland
Neil Nixon
Tim Sweeney
Sandra Simpson
Tim Dalgleish
Rajini Ramana
Min Yang
Richard Morriss
CLAHRC-EM, School of Medicine,, University of Nottingham, Nottingham, United
Kingdom (Prof R Morriss MD, B Guo PhD, C Kaylor-Hughes DPhil)
Adult Mental Health Directorate, Nottinghamshire Healthcare Trust, Nottingham, United
Kingdom (A Garland, RMN, N Nixon, MD, T Sweeney RMN)
Nottinghamshire Healthcare Foundation Trust (Sandra Simpson)
Cambridge and Peterborough Partnership NHS Foundation Trust (R Ramana, MBBS)
Medical Research Council Cognition and Brain Sciences Unit, Cambridge (Prof T Dalgleish
PhD)
West China School of Public Health, Sichuan University, PR China (Prof Min Yang)
Correspondence to:
Professor Richard Morriss, Institute of Mental Health, University of Nottingham, Triumph
Road, Nottingham, NG7 2TU, United Kingdom. Email: richard.morriss@nottingham.ac.uk
2Abstract
Background
The Patient Health Questionnaire-9 (PHQ-9) is a widely used instrument for measuring levels
of depression in patients in clinical practice and academic research; its factor structure has
been investigated in various samples, with limited evidence of measurement
equivalence/invariance (ME/I) but not in patients with more severe depression of long
duration. This study aims to explore the factor structure of the PHQ-9 and the ME/I between
treatment groups over time for these patients.
Methods
187 secondary care patients with persistent major depressive disorder (PMDD) were recruited
to a randomised controlled trial (RCT) with allocation to either a specialist depression team
arm or a general mental health arm; their PHQ-9 score was measured at baseline, 3, 6, 9 and
12 months. Exploratory Structural Equational Modelling (ESEM) was performed to examine
the factor structure for this specific patient group. ME/I between treatment arm at and across
follow-up time were further explored by means of multiple-group ESEM approach using the
best-fitted factor structure.
Results
A two-factor structure was evidenced (somatic and affective factor). This two-factor structure
had strong factorial invariance between the treatment groups at and across follow up times.
Limitations
Participants were largely white British in a RCT with 40% attrition potentially limiting the
study’s generalisability. Not all two-factor modelling criteria were met at every time-point.
Conclusion
PHQ-9 has a two-factor structure for PMDD patients, with strong measurement invariance
between treatment groups at and across follow-up time, demonstrating its validity for RCTs
and prospective longitudinal studies in chronic moderate to severe depression.
Keywords
PHQ-9, factor structure, measurement equivalence/invariance, Exploratory Structural
Equational Modelling, major depressive disorder, chronic depression
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Abbreviations
CFA= confirmatory factor analysis; CFI = comparative fit index; EFA = exploratory factor analysis;
ESEM = exploratory structural equation modelling; ME/I = measurement equivalence/invariance;
NNFI = non-normal fit index; PMDD = persistent major depressive disorder; RMSEA = root mean
square error of approximation; SDS= specialist depression service.
3Introduction
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-reported scale measuring the
symptoms of major depression derived from the Diagnostic and Statistical Manual, (fourth
edition (DSM-IV)) (Kroenke et al., 2001; Spitzer et al., 1999). It can help clinicians quickly
evaluate the severity of a person’s mood and has been applied in various patient populations
such as coronary heart disease (de Jonge et al., 2007), spinal cord injury (Krause et al., 2010),
diabetes (Zhang et al., 2013), and primary care (Baas et al., 2011; Petersen et al., 2015); the
scale has also been used to measure depression in the general population (Yu et al., 2012).
Recently the PHQ-9 was used as a depression measure for secondary care patients with
persistent major depressive disorder (PMDD) in a pragmatic clinical trial conducted in the
UK (Morriss et al., 2010; Morriss et al., 2016). As a well validated and frequently used
instrument, the PHQ-9’s underlying factor structure has been explored for various patient
populations already. However no study has yet investigated the factor structure for specialist
mental health patients with persistent or chronic moderate to severe unipolar depressive
disorder. Understanding the factor structure of PHQ-9 for secondary care patients with
PMDD could help to understand precisely what is being measured by this instrument to aid
the interpretation of studies such as randomised controlled trials of interventions or large
scale mechanistic or epidemiological investigations in this population of patients.
Additionally it could help understand the underlying dimensions and mechanism of long term
unipolar depressive disorder (Elhai et al., 2012).
Studies that have explored the factor structure of PHQ-9 have shown heterogeneous findings
(Petersen et al., 2015), with the number of underlying factors varying between one and two
(Baas et al., 2011; Krause et al., 2010; Richardson and Richards, 2008). These differences
might be due to the different patient populations, physical and mental co-morbidities,
research design and analyses, e.g. using exploratory factor analysis (EFA) compared to
confirmatory factor analysis (CFA). Two-factor structure items have generally been grouped
into two types: somatic (e.g. sleep difficulties, appetite changes and fatigue) and non-
somatic/affective items (e.g. depressed mood, feeling of worthlessness and suicidal thoughts).
However, even with the two-factor structure, there are still some inconsistent item-factor
mapping patterns across studies (Elhai et al., 2012; Petersen et al., 2015). Patients with
PMDD are more likely to have other axis 1 psychiatric disorders; in particular: generalised
anxiety disorder, social phobia, post-traumatic stress disorder and hypochondriasis as well as
more atypical depression and treatment resistance (Rush et al., 2012), which is in itself
associated with melancholia and a number of personality traits (Bennabi et al., 2015).
Clinically, melancholia is associated with more complete loss of pleasure, low energy,
walking and talking more slowly and less reactivity of mood among features measured by the
PHQ-9 (Parker et al., 2013).
Given that PHQ-9 has been used as a depression outcome measure in various studies,
establishing the measurement invariance/equivalence (ME/I) across groups is a logical
prerequisite to conducting substantive cross-group and/or follow-up time comparisons
(Vandenberg and Lance, 2000). Measurement invariance of PHQ-9 was made between male
and female (Petersen et al., 2015) and across ethnic groups (Baas et al., 2011); a further study
by Richardson and Richards (2008) also reported that the PHQ-9 factor structure was
relatively stable across follow-up times for patients with spinal cord injury. However, this
was performed using only exploratory factor analysis (EFA) on PHQ-9 measures collected at
each follow-up time and comparing the factor loading by eye to draw their conclusion. No
formal statistical tests were applied to justify the cross-time measurement invariance
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follow-up time requires further examination.
To make group comparisons of PHQ-9 development across follow-up time points,
longitudinal between-group measurement invariance should be established before making
any valid inference based on comparing PHQ-9 scores between treatment and control groups
across measurement time. Nevertheless, no study has yet investigated the between group
measurement invariance across follow-up time.
EFA and CFA have previously been used to investigate PHQ-9 factor structure (Petersen et
al., 2015; Yu et al., 2012). However, both EFA and CFA have methodological limits
(Asparouhov and Muthén, 2009; Marsh et al., 2014). Using EFA, it is impossible to
incorporate latent EFA factors into subsequent analyses and it is not easy to test measure
invariance across groups and/or times (Marsh et al., 2014).With CFA, each item is strictly
allowed to load on one factor and all non-target loadings are constrained to zero. In applied
research, it is generally justifiable by theory and/or item contents that item(s) could cross load
on different latent factors. Restrictive zero loading typically results in inflated CFA factor
correlation and leads to biased estimates in CFA modelling when other variables are included
in the model (Marsh et al., 2014). The latest methodology development integrates the best
features of both EFA and CFA together as Exploratory Structural Equational Modelling
(ESEM), applying EFA rigorously to specify more appropriately the underlying factor
structure together with applying the advanced statistical methods typically associated with
CFAs (Marsh et al., 2014). Hence, ESEM will be performed to test the factor structure of
PHQ-9 for secondary care patients with PMDD. Measurement invariance tests of PHQ-9
factor structure, i.e. between treatment group invariance at and across follow-up time, will
also be conducted using ESEM.
In summary, the factor structure and measurement invariance between treatment groups
across follow-up time of PHQ-9 for secondary care patients with PMDD will be explored.
This study will apply methodologically rigorous ESEM modelling to explore the factor
structure of the PHQ-9 scale and measurement invariance between treatment groups at and
across follow-up time points.
Method
Patients and instruments
Participants (N = 187) were drawn from a multicentre pragmatic randomised controlled trial
(RCT) evaluating outcomes of a specialist mood disorders team for treatment seeking adults
in secondary mental health care services (Special depression service, SDS) compared to
treatment as usual (TAU). At the time of recruitment participants were receiving treatment in
secondary mental health services from community mental health teams, out-patient and in-
patient units in three mental health trusts across Nottinghamshire, Derbyshire and
Cambridgeshire in the UK.
Participants were eligible for the study if they were: thought by the referrer to have primary
unipolar depression; aged 18 years or over; able and willing to give oral and written informed
consent to participate in the study; had been offered or received direct and continuous care
from one or more health professionals in the preceding 6 months and currently be under the
care of a secondary care mental health team; had a diagnosis of major depressive disorder
with a current major depressive episode according to the structured clinical interview for
DSM-IV (SCID) (First et al., 1997); met five of nine NICE criteria for symptoms of moderate
5depression; had a score of ≥16 on the 17-item Hamilton Depression Rating Scale (HDRS17)
(Williams et al., 2008); and had a Global Assessment of Functioning (GAF) (American
Psychiatric Association, 1994) score ≤ 60. Participants were not included if they were: in 
receipt of emergency care for suicide risk, at risk of severe neglect, or a homicide risk, but
were not excluded because of such risk provided the risk was adequately contained in their
current care setting and the primary medical responsibility for care was with the referral
team; did not speak fluent English; were pregnant; had unipolar depression secondary to a
primary psychiatric or medical disorder, except when bipolar disorder was identified by the
research team after referral with unipolar depression because an SDS would be expected to
manage bipolar depression in clinical practice (n=8, 4.3%).
Of the total 187 patients, 93(49.7%) patients were allocated to the treatment arm and 94
(50.3%) to treatment as usual (TAU) arm. (See Figure 1 for CONSORT diagram of
participant flow through the study). The primary outcome measures were HDRS17 and GAF
which were measured at baseline, 6 and 12 month follow up time points (Morriss et al.,
2010); the secondary outcome measures included Beck Depression Inventory version I (BDI-
I) (Beck et al., 1961), Patient Health Questionnaire (PHQ-9) (Kroenke et al., 2001), Quick
Inventory of Depressive Symptomatology Self-Report (QIDS-SR) (Rush et al., 2006), the
modified Social Adjustment Scale (SAS-M) (Cooper et al., 1982), Patient Doctor
Relationship Questionnaire (PDRQ) (Van der Feltz-Cornelis et al., 2004) and the EQ-5D-3L
(Euroqol Group, 1990). The study design and data collection procedures have been described
in the published protocol (Morriss et al, 2010); more details about the trial and its primary
outcomes can also be found from the trial report by Morriss et al, 2016.
Figure 1 flow of the participants into the study about here
PHQ-9 was a secondary outcome measure used to assess participants’ depression symptoms
and was collected at baseline, 3, 6, 9 and 12 months. The PHQ-9 asks participants to rate the
frequency of depression symptoms they had experienced in the two weeks prior on an ordinal
scale: 0 (not at all), 1 (several days), 2 (more than half the days) and 3 (nearly every day).
Developed from DSM-IV criteria for depressive disorder the PHQ-9 comprises of following
9 items: 1) Little interest or pleasure in doing things; 2) Feeling down, depressed or hopeless;
3) Trouble falling asleep, or sleeping too much; 4) Feeling tired or having little energy. 5)
Poor appetite or overeating; 6) Feeling bad about yourself or that you are a failure or have let
yourself or your family down; 7) Trouble concentrating on things, such as reading the
newspaper or watching television; 8) Moving or speaking so slowly that other people could
have noticed or the opposite being so fidgety or restless that you have been moving around a
lot more than usual; 9) Thoughts that you would be better off dead, or of hurting yourself in
some way. Participants’ item scores are summed up to a total score to reflect the severity of
depression.
Statistics
ESEM was used to explore the factor structure of the PHQ-9 (Marsh et al., 2014). With
reference to existing works on factor structure of PHQ-9, one-factor, two-factor and three-
factor structure models were tested for data across all follow-up times. Measurement
invariance between treatment groups across all follow-up time points for the best fitted factor
structure was also tested using ESEM. For measurement invariance testing the overall
longitudinal measurement invariance test (measuring cross time measurement invariance) for
all participants as one group was conducted first, followed by testing between group
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included the following consecutive steps: configural invariance, metric invariance test (item
factor loading invariance) and scalar invariance (item threshold invariance) test (Vandenberg
and Lance, 2000). The between group measurement invariance across follow-up times was
performed using the same testing order as for overall longitudinal measurement invariance.
However, with each test step, we first tested the model with relevant parameters set to be
equal between groups at each follow-up time, and then moved to test the invariance between
groups across follow-up time periods, i.e. parameters were set equal between groups and
across follow-up time. All ESEM models were performed using software Mplus 7.4 in its
default setting (Muthen and Muthen, 2012). Ordinal item score was analysed with the
WLSMV estimator and missing values were automatically accounted for using the full-
information maximum likelihood approach built into Mplus (Enders and Bandalos, 2001;
Graham, 2003).
Several fitting indices along with chi-square (χ2) test were used to judge model fit as χ2 tests
are sensitive to large sample sizes and non-normal data (Wen et al., 2004). For the
comparative fit index (CFI) and the non-normed fit index (NNFI), values above 0.90
generally indicate models with acceptable fit, a Root Mean Square Error of Approximation
(RMSEA) below 0.08 usually indicates reasonable fit with a threshold of 0.05 reflecting a
close fit to the data (Marsh et al., 2010). Model comparisons were generally evaluated by
reference to the χ2 change test; here we used the Mplus DIFFTEST function to conduct
χ2 difference tests as the WLSMV estimator was used to analyse ordinal items scores
(Muthen and Muthen, 2012). However, χ2 change tests are influenced by sample size and data
non-normality as well (Marsh et al., 2009), i.e. if the sample size is large, a trivial differences
would result in a significant value of χ2 change, which means rejecting the null hypothesis
that there is no real difference between models (Cheung and Rensvold, 2002; Vandenberg
and Lance, 2000). The CFI change is independent of both model complexity and sample size
and not correlated with the overall fit measurements, a reduction of 0.01 or more in CFI
suggests the null hypothesis of no difference should be rejected (Cheung and Rensvold,
2002). We therefore mainly judged model improvement on the CFI change (Guo et al., 2009;
Vandenberg and Lance, 2000). A number of specific modelling details will be presented
alongside the results, the Mplus code performing various ESEM models and a brief overview
of ME/I test procedure may be found at https://doi.org/10.6084/m9.figshare.4622053.v2.
Results
Participants’ background
Participants’ average age was 46.6 years (sd=11.4) with 114 being females (61.5%), mean
duration of illness 16.7 years (sd=11.3, range: 0.5- 49 years), with mean baseline HDRS17
score of 22.6 (sd=8.2, range 16-40), and baseline BDI mean score of 35.0 (sd=8.9, range: 13-
56). More details of participants’ background information including disease status are
presented in Table 1. The trial evidenced statistically and clinically important treatment effect
of differences in change from baseline measure of PHQ-9 at 9 month (-3.5, 95% CI: (-5.7, -
1.3), p=0.002) and 12 month (-2.9, 95% CI: (-5.2, -0.7), p=0.011) compared to general
specialist mental health care. On the primary outcome measure HDRS17 statistically and
clinically important differences did not emerge until 18 months (Morriss et al., 2016). Not all
participants had PHQ-9 scores, with five patients having no PHQ-9 data and were therefore
excluded from the analysis. The actual number of participants having PHQ-9 data are shown
in the last column of Table 2.
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Factor structure of PHQ-9
In line with the modelling steps, results of PHQ-9 factor structure exploration are presented
first, followed by results of the overall longitudinal measurement invariance test and
longitudinal between group measurement invariance tests. Table 2 contains the results of
model fit indices of one-factor, two-factor and three-factor models for data collected at each
time point. The two-factor ESEM model for 12 month data was not convergent so a two-
factor CFA model was run instead, using a model with item-factors mapped as patterns
shown in Table 2, based on reference to the two-factor ESEM factor structure presented from
data collected at the other follow-up time points. The three-factor ESEM and EFA model
were not convergent for baseline and 12 month follow up data. Although the three-factor
ESEM model for 3, 6 and 9 month data fitted the data well, the pattern of factor loading was
very inconsistent across the three data sets and the Eigenvalues for the third factor in each
dataset are less than 1. In addition given the two-factor structure for the PHQ-9 had a
clinically meaningful interpretation and was endorsed by the majority of studies, we decided
not to further explore any PHQ-9 structure with three or more factors. Results in Table 2
showed that the two-factor structure models generally fitted the data better than a one-factor
structure model. The CFI index was >0.90 for both one- and two-factor solutions at each time
point but compared to baseline the two-factor solution varies by -0.012 to 0.021 whereas the
one-factor solution varies by 0.096 over time. The NNFI is >0.90 at all time points for the
two-factor solution but is only 0.875 at baseline. The RMSEA is <0.08 at 3 time-points in the
two-factor solution but only at 2 points in the one-factor solution. The patterns of item-factor
mapping and item factor loading are largely similar across each follow-up data point.
Table 2 about here
Overall measurement invariance across follow-up time
With reference to the results of ESEM modelling for each individual dataset, we put all data
as one group and sequentially ran the measurement invariance test model: configural
invariance, loading invariance and item threshold invariance. The pattern of item-factor
mapping and item factor loadings, which are the result of the invariant loading model, are
presented in Table 3, the model fit indices for each measurement invariance testing model are
presented in Table 4.
Table 3 about here
The configural invariance model result showed the two factor structure model with similar
patterns of item-factor mapping was maintained across follow-up time (2(df)= 1175.59(865),
p<0.001; RMSEA=0.044, CFI=0.947, NNFI=.939) (Table 4). The invariant loading model
fitted data slightly better than the configural invariance model with smaller RMSEA and
increased CFI/NNFI values, in addition to non-significant 2 change. Table 3 results show
item 4 had a cross factor loading (0.415 and 0.350) with slightly higher loading for factor 1
than factor 2. Item 7 and item 1 also had non-negligible cross factor loadings. With reference
to the item content, factor 1 could be termed as an affective factor and factor 2 could be
specified as a somatic factor. For threshold invariance across follow-up time using Mplus
default settings where all latent factor means were fixed to 0 for model identification
purposes (model threshold a in Table 4), the model fitted data well (2(df) = 1546.641(1028),
p<0.001, RMSEA=0.053, CFI=0.911, NNFI=0.915), but the CFI dropped 0.045 i.e. more
than 0.01 cut-off value, from the invariance loading model (threshold a in Table 4). The
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could significantly improve model fitting. However we had to free both factor 1 and 2 mean
estimates as required by the ESEM modelling procedure (Muthen and Muthen, 2012). The
final threshold invariance across follow-up time model (model threshold b in Table 4)
showed 0.005 CFI drop from the invariance loading model. Results in Table 4 showed that
strong factorial invariance was evidenced across follow-up time periods.
Table 4 about here
Between treatment group longitudinal measurement invariance
On top of overall longitudinal measurement invariance, we further tested the between group
longitudinal measurement invariance, i.e. treatment group ME/I at and across follow-up time.
Model fitting indices of each between-group longitudinal measurement invariance model
were presented in Table 5. When performing multiple group CFA with categorical items, the
scale factor had to be fixed to 1 for model identification purposes for the configural
invariance and invariant loading models, but scaled factors were freely estimated in treatment
group for the between group invariant threshold model (Muthen and Muthen, 2012). Hence
the invariant threshold (model 4 in Table 5) and invariant loading model (model 3 in Table 5)
were not nested models; therefore the DIFFTEST can’t be performed directly to test 2
change between Table 5 model 3 and model 4. The 2 change test between model 3 and 4
were therefore tested by Satorra-Bentler scaled 2 change test with modelling using the
WLSM estimator (Satorra and Bentler, 2001). All other model fitting information shown in
Table 5 is from modelling with the default WLSMV estimator.
Table 5 about here
Table 5 shows that all between-group longitudinal invariance models fitted the data well in
that all model CFIs and NNFIs are above 0.9 and RMSEAs are below the 0.08 cut-off value.
ΔCFIs from the previous models are all less than 0.01 cut-off value so the strong factorial 
invariance between groups across follow up time periods for PHQ-9 were evidenced in
secondary care PMDD patients.
Discussion
The PHQ-9 is a widely used instrument for measuring levels of depression in patients in
clinical practice and academic research and though its factor structure has been investigated
in various samples and across demographics, it has not been explored in patients with long-
term moderate to severe depression. Furthermore no formal statistical tests have been applied
to justify the cross-time measurement invariance in PHQ-9 and nor has the between group
measurement invariance across follow-up time been investigated. The factor structure of the
PHQ-9 and the ME/I between treatment groups over time for British psychiatric patients with
PMDD was therefore investigated and it was found that a two-factor structure fitted the data
best. The two factors may be called ‘affective’ and ‘somatic’. The affective factor is
measured by items including “little interest or pleasure in doing things”, “feeling down,
depressed or hopeless”, “feeling tired or having little energy”, “feeling bad about yourself”
and “thoughts of being better off dead”; the somatic factor is measured by items including
“trouble falling asleep”, “poor appetite or overeating”, “trouble concentrating on things” and
“moving or speaking so slowly…”. Most items clearly loaded on only one factor but the item
“Feeling tired or having little energy”, loaded almost equally on both factors while the item
“little pleasure” loaded mainly on the affective factor but also a little on the somatic factor,
9and “poor concentration” loaded mainly on the somatic factor but a little on the affective
factor.
Modelling fitting information comparing one-factor model and two-factor models suggested
that the superiority of the two-factor model decreased over time in follow up. However, this
observed trend was probably a random result due to chance because the one-factor configural
invariance model across follow up time fitted data (CFI=0.920, NNFI=0.915,
RMSEA=0.053, (2(df)= 1404.764(935), P<0.001) worse than the two-factor configural
invariance model (CFI=0.947, NNFI=0.939, RMSEA=0.044, (2(df)= 1175.587(865),
P<0.001). This two-factor structure was found to have strong factorial measurement
invariance both across time and also between treatment groups across follow-up time. The
two-factor structure of PHQ-9 for secondary care PMDD patients is consistent with results
from studies in other populations such as US soldiers and German primary care patients
(Elhai et al., 2012; Petersen et al., 2015). Thus the PHQ-9 is a valid measure of depression
over time in persistent moderate to severe depressed patients in specialist mental health care,
as well as cross-sectionally in less chronic or severe primary care or community samples of
patients with unipolar depressive episodes.
Although a two-factor structure was evidenced in present study, the long term depression
condition and the relevant comorbidities shown in PMDD patients make the PHQ-9 item-
factor association mapping somewhat different from results based on other kind of samples
such as soldiers (Elhai et al., 2012), spine injury patients (Krause et al., 2010) and primary
care patient (Petersen et al., 2015). These studies showed that the somatic factor has five
items with item “Fatigue” generally measuring the non-somatic dimension; but our current
study shows that the item “Fatigue” loaded highly on both the affective factor and the
somatic factor. This might reflect the PMDD patients’ typical comorbidities such as anxiety
and hypochondriasis (Rush et al., 2012) in addition to their persistent melancholia symptoms
(Parker et al., 2013). Furthermore, the ESEM, which allows cross factor loading, provided an
opportunity to investigate the depression factor-items association for PMDD patients
measured by PHQ-9 questionnaire. Unlike CFA results where items loaded on only one
factor, cross factor loadings in ESEM suggested that the depression factor structure measured
by PHQ-9 might not be the same as factors measured in other sample groups, e.g. items
Anhedonia, Fatigue and Concentration Difficulty showed some loading on both somatic and
affective components in PMDD patients. This cross factor loading pattern was largely similar
to the one from an EFA study where depression in spinal cord injury patients’ 25 years post-
injury was explored (Richardson and Richards, 2008) so it may be a feature of depression of
long duration.
Measurement part invariance between groups across follow up time is the logical prerequisite
to meaningfully compare the PHQ-9 score between two treatment groups collected at each
measurement time for making a valid statistical inference, when assessing secondary care
PMDD patients using the PHQ-9. The configural invariance implies that the PHQ-9 items
evoked the same conceptual framework in defining the two latent constructs for both groups
when measured at different times; the invariant item factor loadings show that the association
and patterns mapping the items and factors are stable between two treatment groups across
the 12 month follow up time; the item threshold invariance showed evidence of a trivial
systematic response bias between groups across follow-up time (Vandenberg and Lance,
2000). The invariant item threshold and invariant loading model indicated the existence of
strong factorial invariance, i.e. the measurement scales have the same operational definition
between two groups at and across follow-up time. Hence the between group and cross-time
PHQ-9 mean score comparison is explicitly meaningful (Cheung and Rensvold, 2002).
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Measurement invariance testing also generally includes testing the item uniqueness invariant
between groups and/or across follow-up time (Vandenberg and Lance, 2000), i.e. item
residual variance invariant across follow-up time. Nevertheless, as item score was treated as
an ordinal scale in this study, an item uniqueness invariance model could not be tested
directly as used for modelling with continuous items (Muthen and Muthen, 2012). This
methodological constraint was a limitation of the current study and alternative methodologies
employing invariant item uniqueness should be explored in the future.
There are also other methodological strengths and limitations in this study. The first strength
lies in that the recently developed ESEM approach, which is regarded as having integrated
the benefits of both EFA and CFA (Marsh et al., 2014), was used to investigate the factor
structure of the PHQ-9 and to conduct measurement invariance testing. Cross-factor loadings
between treatment groups were explicitly modelled in the current study with ESEM
advantages. A second strength is that ordinal item scores were analysed using a nonlinear
model which is more appropriate than treating ordinal items as continuous quantities, which
has been the previous approach in factor analysis studies (Elhai et al., 2012; Guo et al., 2011;
Richardson and Richards, 2008; Yu et al., 2012). A third strength is the between group
longitudinal measurement invariance was tested using a multiple group approach with
longitudinal data (Vandenberg and Lance, 2000); this makes good use of Mplus’ built-in
missing value analysis function to take into account missing value information under a
Missing at Random assumption. This approach will increase the power of analysis as all
patients were included in modelling for each measurement time; it also take into account and
estimates the association between factors measured at different time points (Vandenberg and
Lance, 2000).
Limitations include the selection of patients who were all participants in a randomised
controlled trial that excluded patients with a baseline HDRS17 Score below 16 and a GAF
score of above 60. Therefore the results apply only to patients with at least moderate to
severe depression at baseline although some of their scores fell into the mild to moderate
range over time. There may be systematic differences between patients who agree to
participate in a randomised controlled trial of treatment and those that do not; the sample was
on average middle aged and white British, therefore the results may not apply to people with
extremes of age or other ethnic backgrounds. Although PMDD is not strictly the same as
treatment-resistant or chronic depression, the baseline characteristics and chronicity of
depression in this sample suggests that the vast majority of patients would have also met
criteria for both chronic depression and treatment resistant depression.
A further limitation is that not all two-factor model fitting indices, when analysed separately
at each time point, meet the suggested model fitting criteria required for model fitting
evaluation. This could be due to random sampling errors, quite high attrition over time with
the loss of just over 40 per cent of the sample by 12 months or because the trial treatment has
alleviated the depression symptoms. However the same factor structures were evidenced at
each measurement time if all data were modelled simultaneously, suggesting that specialist
depression service treatment with both drug and psychological treatment had not changed the
nature of the depression over time even when the severity of symptoms measured on the
PHQ-9 had reduced. In terms of ESEM modelling, parameter estimates for the ESEM model
cannot be freely fixed to improve the modelling fit with the current version of Mplus. This
remains a methodological challenge.
As a secondary data analysis, the sample size used in this study was pre-specified during trial
design stage (Morriss et al., 2010). A size of 180 of participants was recommended to be
sufficient for most factor analytic modelling under conditions with various numbers of
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factors, the ratio of item/factor and level of communalities (Mundfrom et al., 2005).
Researchers have found that larger sample sizes were not always needed for factor analytical
modelling (MacCallum et al., 1999; Mundfrom et al., 2005; Pearson and Mundform, 2010).
Hence, in the present study, ESEM model fitting results at each follow up time shown in
Table 2 exhibited the same factor analysis modelling at 9 and 12 month follow up times,
despite having fewer patients due to attrition and generally fitted data better than modelling
on baseline, 3 and 6 month data where there were more participants. Nevertheless, a larger
sample size with more items could help to improve factor analysis model fitting (MacCallum
et al., 1999). Our study also showed longitudinal ME/I models with a two-factor structure
fitted data very well, while the ESEM two-factor model using only 12 month follow-up data
couldn’t converge, possibly due to fewer participants following attrition compared to earlier
time points.
In conclusion, the PHQ-9 measure for British secondary care patients with PMDD showed
two underlying latent factors: affective and somatic. This two-factor structure was evidenced
to have strong factorial measurement invariance between treatment arms across follow-up.
Therefore the factor structure of the PHQ-9 is not altered over time nor with combined
psychological and drug treatment suggesting that it is a valid and robust self-rated outcome
measure for further interventional, aetiological or epidemiological research in people with
PMDD, chronic depression or treatment resistant depression in specialist mental health
settings.
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